Regulus Therapeutics Inc (RGLS)
2.65
+0.15
(+6.00%)
USD |
NASDAQ |
May 02, 11:03
Regulus Therapeutics Gross Profit (Quarterly)
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2014 | 1.083M |
| June 30, 2014 | 0.736M |
| March 31, 2014 | 1.631M |
| December 31, 2013 | 5.454M |
| September 30, 2013 | 6.118M |
| June 30, 2013 | 4.759M |
| March 31, 2013 | 3.238M |
| Date | Value |
|---|---|
| December 31, 2012 | 3.238M |
| September 30, 2012 | 2.809M |
| June 30, 2012 | 3.309M |
| March 31, 2012 | 3.344M |
| December 31, 2011 | 3.363M |
| September 30, 2011 | 3.809M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 213.15M |
| ADMA Biologics Inc | 31.09M |
| FibroGen Inc | 21.73M |
| Protara Therapeutics Inc | -- |
| Amylyx Pharmaceuticals Inc | 99.09M |